Education
About Us
Working with TipRanks
Follow Us
VentriPoint Diagnostics (TSE:VPT)
:VPT
RESEARCH TOOLSreports
VPT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.21
Previous CloseN/A
Volume32.00K
Average Volume (3M)116.08K
Market Cap
C$19.20M
Enterprise ValueC$0.00
Total Cash (Recent Filing)C$352.67K
Total Debt (Recent Filing)C$2.13M
Price to Earnings (P/E)―
Beta0.05
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding166,933,530
10 Day Avg. Volume98,166
30 Day Avg. Volume116,077
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-5.31
Price to Sales (P/S)166.31
P/FCF Ratio-4.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VentriPoint Diagnostics News
VPT FAQ
What was VentriPoint Diagnostics’s price range in the past 12 months?
VentriPoint Diagnostics lowest stock price was C$0.07 and its highest was C$0.21 in the past 12 months.
What is VentriPoint Diagnostics’s market cap?
VentriPoint Diagnostics’s market cap is C$19.20M.
When is VentriPoint Diagnostics’s upcoming earnings report date?
VentriPoint Diagnostics’s upcoming earnings report date is Aug 27, 2025 which is in 14 days.
How were VentriPoint Diagnostics’s earnings last quarter?
Currently, no data Available
Is VentriPoint Diagnostics overvalued?
According to Wall Street analysts VentriPoint Diagnostics’s price is currently Overvalued.
Does VentriPoint Diagnostics pay dividends?
VentriPoint Diagnostics does not currently pay dividends.
What is VentriPoint Diagnostics’s EPS estimate?
VentriPoint Diagnostics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VentriPoint Diagnostics have?
VentriPoint Diagnostics has 166,933,530 shares outstanding.
What happened to VentriPoint Diagnostics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VentriPoint Diagnostics?
Currently, no hedge funds are holding shares in TSE:VPT
VentriPoint Diagnostics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Sold Shares
Worth C$17.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-42.50%
12-Months-Change
Fundamentals
Return on Equity
207.08%
Trailing 12-Months
Asset Growth
3.85%
Trailing 12-Months
Company Description
VentriPoint Diagnostics
VentriPoint Diagnostics (VPT) is a medical device company specializing in developing advanced imaging solutions for cardiac diagnostics. The company is focused on improving the assessment of heart function using its proprietary technology that enables accurate and efficient three-dimensional visualization of the heart. VentriPoint's core product, the VMS+ system, offers a non-invasive, cost-effective alternative to traditional imaging methods, aiming to enhance patient care and streamline the diagnostic process in cardiology.
Technical Analysis
Ownership Overview
0.09% Insiders
―
Mutual Funds
― Other Institutional Investors
99.91% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---